Indian Journal of Pharmacology最新文献

{"title":"Clinical usefulness of nebulized dexmedetomidine for conscious sedation in daycare flexible bronchoscopy in Southern India.","authors":"Thomas Antony, K Vishak Acharya, Preetam Rajgopal Acharya, Himani Kotian, Sindhu Kamath","doi":"10.4103/ijp.ijp_160_23","DOIUrl":"10.4103/ijp.ijp_160_23","url":null,"abstract":"<p><strong>Background: </strong>Sedative agents used in bronchoscopy require trained personnel to administer and monitor the patient. This increases the procedure cost, duration, and inpatient stay. Inhalational administration of sedative agents can be a practical solution to the issue. Dexmedetomidine in the inhalational form could give results similar to the intravenous form without significant adverse events.</p><p><strong>Materials and methods: </strong>The study is prospective, randomized, and double-blinded study. Patients needing bronchoscopy were randomized to receive the nebulized form of either dexmedetomidine or saline (0.9%) before bronchoscopy. The study parameters are assessed and recorded before, during, and after bronchoscopy. Data collected are analyzed using the SPSS software.</p><p><strong>Discussion: </strong>The side effects limit using commonly administered sedation agents in bronchoscopy, such as midazolam, fentanyl, and dexmedetomidine. The nebulized dexmedetomidine is safe with proven efficacy when compared to the placebo. Proceduralist-administered conscious sedation reduces the overall cost and shortens inpatient stays. Attenuation of hemodynamic parameters by dexmedetomidine could be an advantage for the physician in reducing an untoward cardiac event.</p><p><strong>Conclusion: </strong>Dexmedetomidine in the nebulized form improves the comfort of patients during the procedure. It blunts the pressure response during bronchoscopy and could be a safer and cost-effective agent in its nebulized form for conscious sedation in bronchoscopy. The study is approved by the institutional ethics committee (IEC KMC MLR 10-2021-310).</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"56 2","pages":"105-111"},"PeriodicalIF":1.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11161002/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140856247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effect of Cleistanthoside A on blood pressure of rats - Can vasoconstrictors help in Cleistanthus collinus poisoning?","authors":"Sajal Clarence Singh, Neetu Prince, Soosai Manickam Amirtham, Sathya Subramani","doi":"10.4103/ijp.ijp_491_23","DOIUrl":"10.4103/ijp.ijp_491_23","url":null,"abstract":"","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"56 2","pages":"146-147"},"PeriodicalIF":1.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11161005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140848369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The efficacy of Punica granatum extract gel in the treatment of symptomatic oral lichen planus in an Indian population: A clinical study.","authors":"Subharina Mahapatra, Manjula Hebbale, Amit Mhapuskar, Rajshekhar Halli, Santosh Jadhav","doi":"10.4103/ijp.ijp_107_23","DOIUrl":"10.4103/ijp.ijp_107_23","url":null,"abstract":"<p><strong>Introduction: </strong>The autoimmune disorder, oral lichen planus (OLP), primarily affects oral mucous membranes. Current drug treatments are only palliative and have serious side effects. Pomegranate has been used as a potential herbal remedy for the treatment of OLP.</p><p><strong>Materials and methods: </strong>The study consisted of a sample size of 30 individuals who were diagnosed with symptomatic OLP based on both clinical and histological evidence and were equally assigned to Group A (4% topical Punica granatum seed extract gel, which has been customized for this particular study purpose only) and Group B (0.1% topical steroid). All patients were evaluated for the outcome criteria of pain, burning sensation, and lesion size.</p><p><strong>Results: </strong>In the present study, results were highly statistically significant (P = 0.001) in intragroup observation for both Group A and Group B from baseline to the end of 30 days of follow-up for all three parameters. There was no statistically significant difference between groups for each week of follow-up.</p><p><strong>Conclusion: </strong>P. granatum has been used in very few studies, but this is one of the few where a gel made from P. granatum seed extract is used as an oral gel. In conclusion, it can be said that topical P. granatum extract gel is as good as topical corticosteroids at getting rid of the signs and symptoms of OLP, so it can be used as an alternative treatment.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"56 2","pages":"84-90"},"PeriodicalIF":1.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11160999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140848370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Antiarthritic potential of ethanolic extract of Ixora coccinea leaves on complete Freund's adjuvant-induced arthritis in animal model.","authors":"Adyasha Anindita Panda, Jayanti Prava Behera, Y Roja Ramani, Abinash Panda, Padmaja Priyadarshini Kar, Snigdha Rani Panigrahy","doi":"10.4103/ijp.ijp_210_23","DOIUrl":"10.4103/ijp.ijp_210_23","url":null,"abstract":"<p><strong>Context: </strong>Ixora coccinea leaves possess antioxidant, anti-inflammatory, antinociceptive, antimutagenic, and gastroprotective properties. On this background, its antiarthritic potential was evaluated.</p><p><strong>Aims: </strong>The objective is to evaluate the effect of Ethanolic extract of Ixora coccinea leaves (EEICL) on complete Freund's adjuvant-induced arthritis in rats.</p><p><strong>Settings and study design: </strong>PG research laboratory, Pharmacology Department, MKCG Medical College, Berhampur, Odisha.</p><p><strong>Subjects and methods: </strong>Thirty-six Wistar albino rats were randomly distributed into sixgroups (n = 6) as follows: Gr 1 (normal control)-DW p.o, Gr-2 (disease control [DC] - Tween 80 p.o), Gr-3 (piroxicam 0.9 mg/kg p.o), Gr-4 (EEICL-1 g/kg, p.o, Gr 4-EEICL-1.5 g/kg p.o, Gr 5-ED50 (0.82 g/kg) + piroxicam (0.45 mg/kg) p.o. After induction of arthritis, drugs, and vehicles were administered daily from 5th to 25th day. On 0, 5th, 10th, 15th, and 25th day, parameters like body weight, rotarod fall time, paw volume displacement, and arthritis index were measured. On the last day, Erythrocyte sedimentation rate (ESR), tissue malondialdehyde (MDA), and histopathological analysis were done.</p><p><strong>Statistical analysis used: </strong>Analysis of parametric data was done by one-way ANOVA and nonparametric data by Kruskal-Wallis test using graph pad prism 7.0. P < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>EEICL (1.5 mg/kg) showed anti-arthritic effect compared with DC. Rotarod fall-off time 137.5 ± 2.5 sec and body weight (139 ± 12.74 g) were increased significantly. The percentage inhibition of paw volume was increased(52%) whereas arthritic score(0.33), ESR(3.51mm/hr), synovial tissue MDA level (0.62±0.13µmol/gm) and Mankin score(2) were reduced significantly as compared to disease control.</p><p><strong>Conclusions: </strong>EEICL has anti-arthritic potential in rat model.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"56 2","pages":"112-119"},"PeriodicalIF":1.4,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11161007/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140850163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tongue and teeth hyperpigmentation in etoposide, prednisolone, vincristine, and cyclophosphamide regimen in the treatment of cutaneous lymphoma","authors":"Soumya Shivalingappa Morabad, Zahed Ullah Khan, Richa Gad, Nikitha Kallur, Irappa Vithoba Madhabhavi, Mallappa Hanumanthappa Shalavadi, Chandrashekhar Venkaraddi Mangannavar","doi":"10.4103/ijp.ijp_53_23","DOIUrl":"https://doi.org/10.4103/ijp.ijp_53_23","url":null,"abstract":"<p>Cutaneous extranodal non-Hodgkin lymphoma is a rare cancer and chemotherapeutic agents like etoposide, vincristine and cyclophosphamide are the drug of choice, which rarely cause hyperpigmentation in skin and nails. However, herein we present a case of hyperpigmentation that was seen in tongue and even in teeth. The hyperpigmentation of the tongue and teeth occurred shortly after the initiation of chemotherapy. Hyperpigmentation was self-limiting and rectified in a week without need of any pharmacological, surgical, or lifestyle interventions.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"1 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2023-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139053419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Investigation of the Asyogh’s rectangular device for learning and memory testing in Wistar rats","authors":"Yogesh Chand Yadav","doi":"10.4103/ijp.ijp_146_23","DOIUrl":"https://doi.org/10.4103/ijp.ijp_146_23","url":null,"abstract":"<p>This study aimed to design Asyogh’s rectangular device that is used for memory testing in rodents. It was found that scopolamine (3 mg/kg i.p.) and diazepam (1 mg/kg i.p.) caused significant memory deficits in rats, as evidenced by increased transfer latency times. However, these memory deficits were significantly reversed when the rats were pretreated with Donepezil. It further demonstrates that pretreated donepezil is able to effectively restore the memory deficits induced by scopolamine and diazepam, as indicated by the significant recovery in TLT. The present study showed that the device used to measure transfer latency time that was a valuable tool for assessing memory and cognitive function in rodents.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"37 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2023-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139053368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A comprehensive review on traditional applications, phytochemistry, pharmacology, and toxicology of Thymus serpyllum","authors":"Deeksha Salaria, Rajan Rolta, Uma Ranjan Lal, Kamal Dev, Vikas Kumar","doi":"10.4103/ijp.ijp_220_22","DOIUrl":"https://doi.org/10.4103/ijp.ijp_220_22","url":null,"abstract":"<p><em xmlns:mrws=\"http://webservices.ovid.com/mrws/1.0\">Thymus serpyllum</em> L. from the Lamiaceae family is an underexplored perennial medicinal shrub with traditional usage in treating respiratory and gastrointestinal issues in the upper foothills of India. This review aims to provide a comprehensive assessment of current knowledge concerning the traditional uses, phytochemistry, and pharmacology of <em xmlns:mrws=\"http://webservices.ovid.com/mrws/1.0\">T. serpyllum</em>. The primary objective is to collect updated information on this plant and encourage further <em xmlns:mrws=\"http://webservices.ovid.com/mrws/1.0\">in vivo</em> and <em xmlns:mrws=\"http://webservices.ovid.com/mrws/1.0\">in vitro</em> research to validate local claims. Notably, the essential oil derived from <em xmlns:mrws=\"http://webservices.ovid.com/mrws/1.0\">T. serpyllum</em> has gained significant attention as a plant-derived product due to its diverse pharmacological properties, including antioxidative, antimicrobial, anti-inflammatory, and anticancer activities. Ethnomedicinal research revealed a vast scope of <em xmlns:mrws=\"http://webservices.ovid.com/mrws/1.0\">T. serpyllum</em> in developing new drugs to address numerous health sector challenges. While <em xmlns:mrws=\"http://webservices.ovid.com/mrws/1.0\">T. serpyllum</em> has been used widely, pharmacological studies are not enough. Most studies are either <em xmlns:mrws=\"http://webservices.ovid.com/mrws/1.0\">in vivo</em> or <em xmlns:mrws=\"http://webservices.ovid.com/mrws/1.0\">in vitro</em>. More studies are required to assess these medicinal claims through well-planned pharmacological experiments. This review will provide the groundwork for future research. While <em xmlns:mrws=\"http://webservices.ovid.com/mrws/1.0\">T. serpyllum</em> has been put to considerable conventional use, pharmacological studies are insufficient; most studies are either <em xmlns:mrws=\"http://webservices.ovid.com/mrws/1.0\">in vivo</em> or <em xmlns:mrws=\"http://webservices.ovid.com/mrws/1.0\">in vitro</em>. More compound isolation, comprehensive pharmacological analysis, and exploration of food applications are vital areas to investigate.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"42 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2023-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139067771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparative evaluation of efficacy and tolerability of apremilast and methotrexate in patients of moderate-to-severe palmoplantar psoriasis: A randomized, parallel, open-label clinical trial","authors":"Mitali Wagh, Jayesh Mukhi, Smita Sontakke, Amit Dhok, Avinash Turankar, Mrunalini Kalikar","doi":"10.4103/ijp.ijp_190_23","DOIUrl":"https://doi.org/10.4103/ijp.ijp_190_23","url":null,"abstract":"<h3>BACKGROUND: </h3>\u0000<p>Variable results about efficacy as well as safety of apremilast compared to methotrexate are reported in different trials. Hence, it is necessary to collect more evidence to prove the role of Apremilast in palmoplantar psoriasis.</p>\u0000<h3>METHODOLOGY: </h3>\u0000<p>The study was a randomized, prospective, parallel-group, open-label study conducted in patients with moderate-to-severe palmoplantar psoriasis. They were randomized into two groups, methotrexate (<em xmlns:mrws=\"http://webservices.ovid.com/mrws/1.0\">n</em> = 19) or apremilast (22) for 16 weeks. Primary efficacy parameter was reduction in modified palmoplantar psoriasis area and severity index (mPPPASI) score from week 0 to week 16. Other parameters were proportion of patients attaining Static Physician Global Assessment score of 0 (clear) or 1 (almost clear), proportion of patients attaining mPPPASI75 (75% reduction in mPPPASI score) at the end of 16 weeks, and proportion of patients showing at least 5-point decline in dermatology life quality index from baseline.</p>\u0000<h3>RESULTS: </h3>\u0000<p>Decline in m-PPPASI score from 0 week to 16 weeks within the group was significant statistically though decline in score of m-PPPASI between these two groups was not statistically significant at 16 weeks. Similar results were obtained with the secondary efficacy parameters. In methotrexate group, there were 24 adverse events recorded including abnormal liver function tests in three patients. In apremilast group, 19 adverse events were recorded, in which two patients suffered from upper respiratory tract infection.</p>\u0000<h3>CONCLUSION: </h3>\u0000<p>Apremilast is as effective as methotrexate for the management of moderate-to-severe palmoplantar psoriasis with better tolerability. Hence, it can be considered alternative to established drugs in patients having palmoplantar psoriasis not responding to or tolerating other drugs.</p>\u0000<h3>REGISTRATION: </h3>\u0000<p>The study was registered with Clinical Trial Registry of India (CTRI/2020/05/025198).</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"62 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2023-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139068010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Does ketamine show tolerance?","authors":"Abhishek Bharadwaj","doi":"10.4103/ijp.ijp_230_23","DOIUrl":"10.4103/ijp.ijp_230_23","url":null,"abstract":"","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"55 6","pages":"410-411"},"PeriodicalIF":1.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10821698/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139086701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The clinical effect of ossotide for injection in the treatment of condylar fracture.","authors":"Qian Jiang, Yifei Chen, Fangyong Zhu, Yujia Xie, Zhidan Zhu, Xiaojing Sun","doi":"10.4103/ijp.ijp_157_23","DOIUrl":"10.4103/ijp.ijp_157_23","url":null,"abstract":"<p><strong>Objectives: </strong>Patients with condylar fractures were treated with osteopeptide injections as an adjuvant therapy to assess pain control and changes in interleukin-1β (IL-1β) and bone G-gla protein (BGP) levels.</p><p><strong>Materials and methods: </strong>Eighty-two patients with a condylar neck fracture were randomly assigned to two groups. The control group received conventional surgical treatment, while the experimental group received osteopeptide injections in addition to surgery. Pain level, IL-1β, and BGP levels were evaluated at 1, 2, and 4 weeks postsurgery.</p><p><strong>Results: </strong>One and two weeks postsurgery, the experimental group had lower Numeric Rating Scale scores compared to the control group. In addition, the IL-1β level in patients receiving osteopeptide injections was lower than the control group at all three evaluation points (1, 2, and 4 weeks postsurgery) and the BGP level was higher with statistically significant differences (P < 0.05).</p><p><strong>Conclusions: </strong>The administration of osteopeptide injections as an adjuvant therapy for patients with condylar fractures can effectively reduce pain and facilitate faster initiation of muscle function training. In addition, the reduction of inflammatory factors and promotion of active osteogenesis leads to quicker wound healing.</p>","PeriodicalId":13490,"journal":{"name":"Indian Journal of Pharmacology","volume":"55 6","pages":"363-366"},"PeriodicalIF":1.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10821697/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139086707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}